Color Study (High-Risk Breast Lesions) - Clinical Trial

What is the Purpose of this Study?

If you choose to join this study, you will:

  • Give a saliva sample
  • Have a genetic test using the Color Genomics 30 gene hereditary panel test
What is the Condition Being Studied?

Genetic Testing

Who Can Participate in the Study?

Women diagnosed with high-risk breast lesions, which include:

  • Lobular carcinoma in situ (LCIS)
  • Atypical ductal hyperplasia (ADH)
  • Atypical lobular hyperplasia (ALH)
  • Flat epithelial atypia (FEA)
  • Columnar cell hyperplasia (CCH)
Age Group
Adults

What is Involved?

We are doing this study to screen women diagnosed with high-risk breast lesions for genetic mutations that may be linked to a future risk of cancer.

Study Details

Full Title
Genetic testing for women with high-risk breast lesions
Principal Investigator
Surgical Oncologist
Protocol Number
IRB: PRO00089223
NCT: NCT00000000
Phase
Phase N/A
ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Participate